Pharmaceutical - Pharmaceutical, North America, South America

Call for strong Trans-Pacific intellectual property framework from PhRMA

05-03-2013

The Pharmaceutical Research and Manufacturers of America (PhRMA) this week called on nations participating…

Asia-PacificBiotechnologyNorth AmericaPatentsPharmaceuticalSouth America

Bristol-Myers gets $438 million under Latin America OTC deal with Reckitt Benckiser; Baraclude patent ruled invalid

13-02-2013

US pharma major Bristol-Myers Squibb (NYSE: BMY) has entered into a three-year collaboration agreement…

Anti-viralsBaracludeBristol-Myers SquibbGenericsLicensingNorth AmericaPatentsPharmaceuticalReckitt BenckiserSouth AmericaTeva Pharmaceutical Industries

Tranzyme exploring options, including sale of the firm; is Ache up for sale?

11-02-2013

Following two recent R&D pipeline disappointments, the board of directors of US biotech firm Tranzyme…

Ache Laboratorios FarmaceuticosBiotechnologyMergers & AcquisitionsNorth AmericaPharmaceuticalSouth AmericaTranzyme

AstraZeneca in two more Seroquel XR patent settlements; Actavis outlines South America aims

06-10-2011

In further patent settlements in the USA, Anglo-Swedish drug major AstraZeneca (LSE: AZN) has now announced…

Accord HealthcareActavisAstraZenecaGenericsIntas PharmaceuticalsLegalMarkets & MarketingNeurologicalNorth AmericaPatentsPharmaceuticalSeroquel XRSouth America

Company Spotlight

ImmunoGen

ImmunoGen

Back to top